'Orphan' drugs are used to treat rare diseases and are so called because the pharmaceutical industry has little financial interest in developing and marketing products intended for only a small number of patients suffering from very rare conditions.
European Commission
Public Health
Accessibility tools
Service tools
Language selector
Navigation path
- European Commission
- Public health
- Rare diseases
- Orphan medicinal products
